Table 1.
Gene | Targeted exons(s) | Forward primer (5′ –> 3′) | Reverse primer (5′ –> 3′) | Size (bp) | PCR conditions |
---|---|---|---|---|---|
BRAF | 14 and 15 | GCACAGGGCATGGATTACTT | GATGACTTCTGGTGCCATCC | 194 | Std but Tm at 55°C |
NRAS | 3 | CGCACTGACAATCCAGCTAA | TCGCTTAATCTGCTCCCTGT | 255 | Std |
HRAS | 3 | GGAAGCAGGTGGTCATTGAT | ACGTCATCCGAGTCCTTCAC | 204 | Std |
KRAS | 3 | AGAGAGGCCTGCTGAAAATG | TTGACCTGCTGTGTCGAGAA | 200 | Std |
TP53-1 | 2, 3, 4, 5 | GTGACACGCTTCCCTGGAT | ACACGCAAATTTCCTTCCAC | 658 | Std |
TP53-2 | 5, 6, 7 | CCCTTCCCAGAAAACCTACC | AGCTGTTCCGTCCCAGTAGA | 518 | Std |
TP53-3 | 6, 7, 8, 9, 10, 11 | GCTGCTCAGATAGCGATGGT | GTGGGAGGCTGTCAGTGG | 660 | Std |
PI3KCA-1 | 9, 10, 11 | TGACTGGTTCAGCAGTGTGG | GGCCAATCTTTTACCAAGCA | 341 | Std |
PI3KCA-2 | 20, 21 | TTTTGACACAGGATTTCTTAATAGTGA | GGTCTTTGCCTGCTGAGAGT | 418 | Std but Tm at 55°C |
PAX8/PPARγ | Pax8: 8, 9, 10 PPARγ: 3 8, 9 8, 10 8, 9 | GCAACCTCTCGACTCACCAG (PAX8) | CATTACGGAGAGATCCACGG (PPARγ) | 407 305 217 108 | Std |
RET/PTC1 | RET:12, 13 H4: 1 | GGCACTGCAGGAGGAGAAC (H4) | GATGACATGTGGGTGGTTGA (RET) | 277 | Std |
RET/PTC3 | RET:12, 13 ELE1: 7 | AAGCAAACCTGCCAGTGG (ELE1) | TGCTTCAGGACGTTGAAC (RET) | 240 | Std but with 30 cycles |
PTEN-1 | 4, 5, 6 | GACATTATGACACCGCCAAA | CGCCACTGAACATTGGAATA | 405 | Std |
PTEN-2 | 6, 7, 8, 9 | GCTACCTGTTAAAGAATCATCTGGA | TGACGGCTCCTCTACTGTTTT | 530 | Std but Tm at 48°C |
PBGD | 11, 12, and 13 | AAGGACCAGGACATCTTGGA | AACTGTGGGTCATCCTCAGG | 266 | Std but Tm at 55°C |
Std: Standard conditions: 94°C for 5 min followed by 35 cycles consisting of incubations at 94°C for 30 s, 60°C (Tm) for 1 min and 72°C for 1 min. At the end of cycles the PCR mixtures were incubated at 72°C for 10 min. PBGD gene was used as a positive control for amplification. For each PCR, a negative control (the amplification mix without DNA) was used to detect possible contamination.